Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.41 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.41 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7076729 | 0.88 | MTNR1B (0.45) | TP53NPC1RAB9AMAPTMEN1 | |
| SCHEMBL7081568 | 0.84 | PTK2 (0.41) | GAAMAPTMAPK1RXFP1SGMS2 | |
| SCHEMBL7077440 | 0.84 | MAPT (0.41) | GAAMAPTMAPK1MEN1KMT2A | |
| SCHEMBL7080331 | 0.84 | SGMS2 (0.52) | MEN1KMT2ARXFP1SGMS2 | |
| SCHEMBL7080643 | 0.77 | RAB9A (0.43) | RAB9AGAAMAPTMAPK1MEN1 | |
| SCHEMBL7083369 | 0.77 | RAB9A (0.43) | RAB9AGAAMAPTMAPK1MEN1 | |
| SCHEMBL7080256 | 0.77 | HSD17B10 (0.50) | TP53NPC1RAB9AGAAMAPT | |
| SCHEMBL7083951 | 0.76 | SMN1; SMN2 (0.56) | NPC1RAB9AMAPTMAPK1MEN1 | |
| SCHEMBL7078520 | 0.76 | ALDH1A1 (0.53) | GAAMEN1KMT2A | |
| SCHEMBL7076725 | 0.74 | MTNR1B (0.48) | TP53NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | AJINOMOTO CO. INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| US-6555584-B1 | Acetyl-coa carboxylase inhibitors | AJINOMOTO CO., INC. (JP) | 2003-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | ACSS2, ACACA, FASN | CAPN1 481/4885PPARG 478/4885TP53 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.